Literature DB >> 4026937

The effect of selective breeding on the development of coronary atherosclerosis in WHHL rabbits. An animal model for familial hypercholesterolemia.

Y Watanabe, T Ito, M Shiomi.   

Abstract

To increase the incidence of coronary atherosclerosis in Watanabe heritable hyperlipidemic (WHHL) rabbits, an animal model for familial hypercholesterolemia, selective breeding has been carried out. The results obtained are as follows: The incidence of coronary atherosclerosis before selective breeding was 21.8%, whereas that after the breeding was 58.9% (average values for rabbits between 4 and 12 months old), showing that the incidence of coronary atherosclerosis can be increased by an appropriate breeding technique. With respect to the relationships between parents and offspring, if parents had coronary atherosclerosis, then the incidence of the disease in the offspring was 83.3%; therefore the disease was strongly heritable. The mean total cholesterol (TC) and triglyceride (TG) levels of the colony before selective breeding were 579 +/- 163 mg/dl and 471 +/- 144 mg/dl, respectively, while those after the breeding were 665 +/- 151 mg/dl and 603 +/- 178 mg/dl; serum lipid levels increased in parallel with incidence of coronary atherosclerosis. The earliest development of coronary atherosclerosis in the colony after selective breeding was found in 4-month-old rabbits and the whole colony suffered from the disease at 18 months of age.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4026937     DOI: 10.1016/0021-9150(85)90085-1

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  11 in total

Review 1.  Immunology of atherosclerosis: the promise of mouse models.

Authors:  A H Lichtman; M Cybulsky; F W Luscinskas
Journal:  Am J Pathol       Date:  1996-08       Impact factor: 4.307

Review 2.  Cardiovascular gene therapy for myocardial infarction.

Authors:  Maria C Scimia; Anna M Gumpert; Walter J Koch
Journal:  Expert Opin Biol Ther       Date:  2013-12-16       Impact factor: 4.388

3.  Disease-corrected hepatocyte-like cells from familial hypercholesterolemia-induced pluripotent stem cells.

Authors:  Faranak Fattahi; Samira Asgari; Behshad Pournasr; Ali Seifinejad; Mehdi Totonchi; Adeleh Taei; Nasser Aghdami; Ghasem Hosseini Salekdeh; Hossein Baharvand
Journal:  Mol Biotechnol       Date:  2013-07       Impact factor: 2.695

4.  Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia.

Authors:  T Kita; Y Nagano; M Yokode; K Ishii; N Kume; A Ooshima; H Yoshida; C Kawai
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

5.  Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery.

Authors:  S Ishibashi; M S Brown; J L Goldstein; R D Gerard; R E Hammer; J Herz
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

Review 6.  Roles of the WHHL rabbit in translational research on hypercholesterolemia and cardiovascular diseases.

Authors:  Tsutomu Kobayashi; Takashi Ito; Masashi Shiomi
Journal:  J Biomed Biotechnol       Date:  2011-04-19

7.  LDLR-Gene therapy for familial hypercholesterolaemia: problems, progress, and perspectives.

Authors:  Faisal A Al-Allaf; Charles Coutelle; Simon N Waddington; Anna L David; Richard Harbottle; Michael Themis
Journal:  Int Arch Med       Date:  2010-12-13

8.  The History of the WHHL Rabbit, an Animal Model of Familial Hypercholesterolemia (II) - Contribution to the Development and Validation of the Therapeutics for Hypercholesterolemia and Atherosclerosis.

Authors:  Masashi Shiomi
Journal:  J Atheroscler Thromb       Date:  2019-11-21       Impact factor: 4.928

9.  Animal models of coronary heart disease.

Authors:  Jiawei Liao; Wei Huang; George Liu
Journal:  J Biomed Res       Date:  2015-08-20

10.  The History of the WHHL Rabbit, an Animal Model of Familial Hypercholesterolemia (I) - Contribution to the Elucidation of the Pathophysiology of Human Hypercholesterolemia and Coronary Heart Disease.

Authors:  Masashi Shiomi
Journal:  J Atheroscler Thromb       Date:  2019-11-21       Impact factor: 4.928

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.